An abnormal sense of touch was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to 0.7% on placebo
Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6) Prog Growth Factor Res
Food and Foodways, 33(3), 244-262
Her return to competition has sparked conversation and fanfare across the sports worldon Monday, Nike released an ad celebrating the moment that also features LeBron James
Direct answer: GLP-1 medications normally slow stomach emptying, but severe, worsening, or persistent digestive symptoms may require medical evaluation
Consult your physician or pharmacist for correct usage, compatibility, and safety precautions specific to the drug being prepared